COX CARRIE SMITH 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
COX CARRIE SMITH
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+8,000→ 8,000 totalExercise: $16.93From: 2026-01-02Exp: 2035-01-01→ Common Stock (8,000 underlying) - Award
Common Stock
2025-01-02+2,600→ 15,629 total
Holdings
- 8,266
Stock Option (Right to Buy)
Exercise: $19.66Exp: 2034-01-01→ Common Stock (8,266 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.
- [F2]On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F3]This award vests in 36 equal monthly installments following the date of grant, so that it shall be fully vested on January 2, 2027.